Catalyst Wire Dossier Catalyst Wire Dossier

PCC

· Mateon Therapeutics
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for PCC, covering 2020-11-17 to 2025-03-24. Get the full timeline:

Most recent: Clinical Trial Update: FOCUS: PCC + Bevacizumab + CA4P Versus PCC + Bevacizumab + Placebo for Subjects With Platinum Resistant Ovarian Cancer [Phase 2, Phase 3]

See pricing